A CLINICAL STUDY TO EVALUATE THE EFFICACY OF VAMANA KARMA IN THE MANAGEMENT OF DYSLIPIDEMIA
DOI:
https://doi.org/10.22159/ajpcr.2018.v11i12.27698Keywords:
Dyslipidemia, Medodushti, Abaddha meda, Kaphavikara, VamanaAbstract
Objective: The aim of the present study is to evaluate the efficacy of Vamana karma in the management of dyslipidemia.
Methods: Patients were selected from the OPD and IPD at the Department of Panchakarma, Hospital of Rishikul Campus, Uttarakhand Ayurved University, Haridwar. Patients in Group A will be administered with two sittings of Vamana procedure. In Group B, 20 patients will be treated with atorvastatin for 60 days in dose of 10 mg once daily after meals with water.
Results: The overall assessment of the therapy was decided on the basis of improvement in biochemical parameter (serum lipid profile) by applying statistics. Vamana karma had statistically highly significant result in all the objective parameters except high-density lipoprotein [HDL].
Conclusion: Thus, it can be concluded that dyslipidemia is a form of Kaphavikara specifically may be Medodushti in the form of Abaddha meda. Vamana karma is highly effective in correcting serum lipid profile except HDL and very low-density lipoprotein but have better effect than the standard drug in both of them. Vamana karma can be used for the effective and safe management of dyslipidemia.
Downloads
References
Kasper DL, Fauci AS, Hauser SL, Longo DL, Jameson JL, Loscalzo J. Harrison’s Manual of Medicine, Endocrinology and Metabolism. 19th ed. Ch. 16. New Delhi: MC Graw Hill Publication; 2008. p. 2438.
Priyanga S, Mary MR, Hemmalakshmi S, Devaki K. Anti hyperlipidemic effect of aqueous extract of Aegle marmelos and Camellia sinensis in oil fed hyperlipidemic rats. Int J Pharm Pharm Sci 2014;6:338-41.
Vishwas NA, Raj KK. An ayurvedic polyherbal formulation PDBT for dyslipidemia and prevention of coronary artery disease (CAD) in pre-diabetic individuals. Int J Res Ayurved Pharm 2013;4:701-4.
The World Health Report. Reducing Risks, Promoting Healthy Life, Executive Summary. Technical Report Series. Geneva: World Health Organisation, Publications; 2002.
Khairnar A, Shelke S, Rathod V, Kalawane Y, Jagtap A. Review on antihyperlipidemic lipophilic drugs and their novel formulation approaches. Int J Pharm Pharm Sci 2017;9:1-8.
Available from: http://www.webmd.com/cholesterol-management/side-effects-of-statin-drugs. [Last accessed on 2018 Mar 14].
Agnivesha. Charaka Samhita-Ayurveda Dipika Commentary of Chakrapanidatta. In: Dwiwedi L, editor. Revised Edition. Nidanasthana 4/7, Varanasi: Chaukhamba Krishanadas Academy; 2008. p. 703.
Sastri PT. Vidyotini Hindi Commentary. Revised edition. Sutra Sthana 16/20. Varanasi: Chaukhamba Bharati Academy; 2008. p. 321.
Sastri PT. Vidyotini Hindi Commentary. Revised edition. Sutra Sthana 23/8. Varanasi: Chaukhamba Bharati Academy; 2008. p. 437.
Gupta B, Mahapatra SC, Makhija R, Kumar A, Jirankalgikar NM, Padhi MM, et al. Physiological and biochemical changes with vamana procedure. Ayu 2012;33:348-55.
Sharma S, Bhatted SK. Effect of classical Vamana Karma (therapeutic emesis) in dyslipidemia (medoroga)-A case study. Int Ayurvedic Med J 2015;3:1737-40.
Sharma S, Bhatted SK. The effect of Vamana Karma (therapeutic emesis) with Dhamargava Beeja yoga (luffa cylindrica) followed by lekhaneeya Ghana Vati in the management of Dyslipidemia (Medoroga). World J Pharm Res 2016;5:1632-42.
Published
How to Cite
Issue
Section
The publication is licensed under CC By and is open access. Copyright is with author and allowed to retain publishing rights without restrictions.
